Eli Lilly and Company: all 2,262 studies
Page 6 of 23. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque PsoriasisCompletedNCT03482011Phase 3Results posted
- Tau Screening Study in Subjects With Early Symptomatic ADCompletedNCT03467477Phase 2Results posted
- A Study of LY900014 in Participants With Type 1 Diabetes MellitusCompletedNCT03465878Phase 1Results posted
- A Study of Lasmiditan on the Heart in Healthy ParticipantsCompletedNCT03465436Phase 1Results posted
- A Study of Lasmiditan on Simulated Driving Performance in Healthy ParticipantsCompletedNCT03459612Phase 1Results posted
- A Study of LY3074828 in Healthy ParticipantsCompletedNCT03456713Phase 1Results posted
- A Meal Test Study of LY900014 in Participants With Type 1 Diabetes MellitusCompletedNCT03449433Phase 1Results posted
- A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT03443024Phase 2Results posted
- A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic DermatitisCompletedNCT03435081Phase 3Results posted
- A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 DiabetesCompletedNCT03433677Phase 3Results posted
- A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically AdvisableCompletedNCT03428100Phase 3Results posted
- A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes MellitusCompletedNCT03421379Phase 3Results posted
- A Study of LY3316531 in Healthy Participants and in Participants With PsoriasisCompletedNCT03418493Phase 1Results posted
- A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian CancerCompletedNCT03414047Phase 2Results posted
- A Study of LY900014 in Japanese Participants With Type 1 Diabetes MellitusCompletedNCT03407118Phase 1Results posted
- A Study of Lasmiditan in Healthy Elderly ParticipantsCompletedNCT03406260Phase 1Results posted
- Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung CancerTerminatedNCT03382912Phase 2Results posted
- Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung CancerTerminatedNCT03382899Phase 2Results posted
- A 3-Way Crossover Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)CompletedNCT03381547Phase 1Results posted
- A Study of Tirzepatide (LY3298176) in Healthy ParticipantsCompletedNCT03375463Phase 1Results posted
- Assessment of Mealtime Bolus Insulin BehaviorCompletedNCT03368807Results posted
- A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)CompletedNCT03367403Phase 2Results posted
- A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque PsoriasisCompletedNCT03364309Phase 3Results posted
- A Study of Dulaglutide in Healthy ParticipantsCompletedNCT03363906Phase 1Results posted
- A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)CompletedNCT03341312Phase 1Results posted
- A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes MellitusCompletedNCT03341299Phase 1Results posted
- A Study of Nasal Glucagon in Participants With Type 1 Diabetes MellitusCompletedNCT03339453Phase 1Results posted
- A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes MellitusCompletedNCT03338023Phase 3Results posted
- A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes MellitusCompletedNCT03338010Phase 3Results posted
- A Study to Compare 2 Formulations of LY900014 in Healthy ParticipantsCompletedNCT03334448Phase 1Results posted
- A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic DermatitisCompletedNCT03334435Phase 3Results posted
- Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic DermatitisCompletedNCT03334422Phase 3Results posted
- A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic DermatitisCompletedNCT03334396Phase 3Results posted
- A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 DiabetesCompletedNCT03322631Phase 1Results posted
- Tau Screening Study in Patients With Early Symptomatic ADCompletedNCT03322462Phase 2Results posted
- A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 DiabetesCompletedNCT03315780Phase 4Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 DiabetesCompletedNCT03311724Phase 2Results posted
- A Study of Lasmiditan When Given With Sumatriptan in Healthy ParticipantsCompletedNCT03310411Phase 1Results posted
- A Study of Lasmiditan in Healthy Participants When Co-administered With TopiramateCompletedNCT03308669Phase 1Results posted
- A Study of LY900014 in Participants With Type 2 Diabetes MellitusCompletedNCT03305822Phase 1Results posted
- A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)CompletedNCT03305809Phase 2Results posted
- A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy ParticipantsCompletedNCT03286751Phase 1Results posted
- A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug UsersCompletedNCT03286218Phase 1Results posted
- A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue SarcomaCompletedNCT03283696Phase 1Results posted
- A Study of Lasmiditan and Propranolol in Healthy ParticipantsCompletedNCT03270644Phase 1Results posted
- A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)CompletedNCT03267732Phase 1Results posted
- A Study of Multiple Doses of Lasmiditan in Healthy ParticipantsCompletedNCT03252015Phase 1Results posted
- A Study of Lasmiditan in Participants With MigraineCompletedNCT03247790Phase 1Results posted
- A Study of LY900014 Formulation at Different Injection Sites in Healthy ParticipantsCompletedNCT03232983Phase 1Results posted
- A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 DiabetesCompletedNCT03214380Phase 3Results posted
- A Study of LY900014 in Participants With Type 1 DiabetesCompletedNCT03214367Phase 3Results posted
- A Study of Baricitinib in Healthy ParticipantsCompletedNCT03212638Phase 1Results posted
- A Study of Two Different Formulations of LY3074828 in Healthy ParticipantsCompletedNCT03188510Phase 1Results posted
- A Study of Lasmiditan in Healthy ParticipantsCompletedNCT03182920Phase 1Results posted
- A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes MellitusCompletedNCT03166124Phase 1Results posted
- A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)Active, not recruitingNCT03157128Phase 1/2Results posted
- Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast CancerActive, not recruitingNCT03155997Phase 3Results posted
- A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic ArthritisCompletedNCT03151551Phase 4Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes MellitusCompletedNCT03131687Phase 2Results posted
- A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial SpondyloarthritisCompletedNCT03129100Phase 3Results posted
- A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne VulgarisCompletedNCT03127956Phase 3Results posted
- A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue SarcomaCompletedNCT03126591Phase 1Results posted
- A Study of LY3337641 in Healthy ParticipantsCompletedNCT03099148Phase 1Results posted
- A Study of AK-01 (LY3295668) in Solid TumorsCompletedNCT03092934Phase 1/2Results posted
- A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic CancerCompletedNCT03086369Phase 1/2Results posted
- A Study of LY3337641 in Japanese and Caucasian Healthy ParticipantsCompletedNCT03083561Phase 1Results posted
- Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy ParticipantsCompletedNCT03076970Phase 1Results posted
- A Study of Olumacostat Glasaretil Gel in Subjects With Acne VulgarisCompletedNCT03073486Phase 3Results posted
- A Study of Ixekizumab in Chinese Participants With Psoriasis VulgarisCompletedNCT03073213Phase 1Results posted
- Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque PsoriasisCompletedNCT03073200Phase 3Results posted
- A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin PumpCompletedNCT03056456Phase 1Results posted
- A Study of Mirikizumab (LY3074828) Injection in Healthy ParticipantsCompletedNCT03053622Phase 1Results posted
- Flortaucipir 18F PET Imaging in BIOCARD StudyTerminatedNCT03052972Phase 1Results posted
- Flortaucipir PET Imaging in Subjects With FTDCompletedNCT03040713Phase 1Results posted
- Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic FunctionCompletedNCT03040479Phase 1Results posted
- Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose AdministrationCompletedNCT03040362Phase 1Results posted
- A Study of Olumacostat Glasaretil Gel in Subjects With Acne VulgarisCompletedNCT03028363Phase 3Results posted
- A Study of LY3202626 in Healthy ParticipantsCompletedNCT03023826Phase 1Results posted
- A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's DiseaseCompletedNCT03019536Phase 1Results posted
- A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes MellitusCompletedNCT03018938Phase 4Results posted
- The Effects of Lasmiditan on Simulated Driving Performance - Healthy ParticipantsCompletedNCT03012334Phase 1Results posted
- Study of Oral Lasmiditan in Participants With Normal and Impaired Renal FunctionCompletedNCT03009162Phase 1Results posted
- A Study of Ixekizumab in Participants With Plaque PsoriasisCompletedNCT02993471Phase 1Results posted
- A Study of LY3323795 in Healthy ParticipantsCompletedNCT02989389Phase 1Results posted
- A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal AdenocarcinomaCompletedNCT02981342Phase 2Results posted
- A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin MonotherapyCompletedNCT02973100Phase 2Results posted
- A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 DiabetesCompletedNCT02963766Phase 3Results posted
- A Study of LY2951742 (Galcanezumab) in Japanese Participants With MigraineCompletedNCT02959190Phase 3Results posted
- A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic MigraineCompletedNCT02959177Phase 2Results posted
- A Study of LY3185643 and rGlucagon in Healthy ParticipantsCompletedNCT02951780Phase 1Results posted
- A Study of LY900014 Formulation in Healthy ParticipantsCompletedNCT02942654Phase 1Results posted
- Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic CancerCompletedNCT02923921Phase 3Results posted
- A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic CancersCompletedNCT02919696Phase 1Results posted
- A Study of the Absorption, Distribution, Metabolism and Excretion of LY3039478 in Healthy ParticipantsCompletedNCT02917733Phase 1Results posted
- A Study of LY3337641 in Healthy Male ParticipantsCompletedNCT02914379Phase 1Results posted
- Study of LY3039478 in Healthy ParticipantsCompletedNCT02906618Phase 1Results posted
- A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque PsoriasisCompletedNCT02899988Phase 2Results posted
- A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal CancerCompletedNCT02898077Phase 3Results posted
- A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's DiseaseCompletedNCT02891226Phase 2Results posted
- A Study of the Effect of Abemaciclib on Metformin and Iohexol in Healthy ParticipantsCompletedNCT02884089Phase 1Results posted